﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropathology</JournalTitle>
      <Issn>2251-8363</Issn>
      <Volume>12</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Prevalence of hyponatremia in hospitalized patients with coronavirus disease 2019; a multicenter study</ArticleTitle>
    <FirstPage>e18383</FirstPage>
    <LastPage>e18383</LastPage>
    <ELocationID EIdType="doi">10.34172/jnp.2022.18383</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sepideh</FirstName>
        <LastName>Hajian</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-5404-2765</Identifier>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Sarbazi-Golezari</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-4570-5472</Identifier>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Karbasi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4545-6143</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jnp.2022.18383</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>01</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>05</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: In patients with coronavirus disease 2019 (COVID-19), the prevalence of hyponatremia has been reported with varying outcomes. Objectives: The aim of this study was to evaluate the prevalence of hyponatremia in hospitalized patients with COVID-19. Patients and Methods: In this multicenter cross-sectional study, information about hospitalized patients with COVID-19 admitted between March 2020 and September 2020, including age, gender, and serum levels of sodium, creatinine, and potassium, as well as blood urea nitrogen (BUN), was analyzed, while P value level less than 0.05 was considered significant. Results: A total of 667 hospitalized patients with COVID-19 were enrolled in the study, of which 54.4% were male. The median age of patients was 63 years old. About 39.4% of patients had hyponatremia on admission day. More than 80% of patients had mild hyponatremia. The median age of the hyponatremia group was significantly higher than that of eunatremia group. Conclusion: Our data showed that hyponatremia is observed in hospitalized patients with COVID-19 and is often mild. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Hyponatremia</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Pneumonia</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Hospitalization</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">COVID-19</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Prevalence</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>